COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
NanoViricides, Inc. Has Filed its Quarterly Report: Broad-Spectrum Antiviral NV-387 To Combat MPox Pandemic in Africa - Phase II Clinical Trial Update, Also Readying to Combat Measles Outbreaks, and to Tackle Bird Flu
NanoViricides, Inc. reports filing Form 10-Q for quarter ending March 31, 2025 with SEC. Clears Phase II trial for NV-387 drug to treat MPox disease & explores Measles and Bird Flu treatments. Company has strong financials -
COMMUNIQUÉ DE PRESSE
IBU-tec advanced materials AG publishes final figures and Annual Report 2024 / EBITDA at the upper end of the forecast range
IBU-tec advanced materials AG publishes final figures and Annual Report 2024, with EBITDA at the upper end of the forecast range. Revenue increases to EUR 50.6 million in 2024 -
-
-
-
COMMUNIQUÉ DE PRESSE
DN Deutsche Nachhaltigkeit: International Impact Forum (IIF) on June 4, 2025 with a top-class program and top speakers
DN Deutsche Nachhaltigkeit AG to host International Impact Forum (IIF) on June 4, 2025, featuring top speakers discussing sustainability, impact investing, and the Green Deal -
-
COMMUNIQUÉ DE PRESSE
H&R Holding GmbH announces voluntary public tender offer for all outstanding shares of H&R GmbH & Co. KGaA
H&R Holding GmbH announces a voluntary public tender offer to increase shareholding in H&R GmbH & Co. KGaA, offering a secure premium to shareholders for transformation and delisting potential -
